Predictive Value of Node Reporting and Data System for Lymph Node Involvement in Prostate Cancer: A Matched Cohort
Sacit Nuri Gorgel1, Yigit Akin1, Enis Mert Yorulmaz2
1Department of Urology, Izmir Katip Celebi University, Izmir, Turkey.
Urologia Internationalis
|November 3, 2025
Summary
The Node-RADS system accurately predicts lymph node involvement in prostate cancer (PCa) using MRI. This imaging tool aids in risk stratification and selecting patients for further treatment.
Area of Science:
- Radiology
- Urology
- Oncology
Background:
- Prostate cancer (PCa) management requires accurate staging.
- Assessing lymph node involvement (LNI) is crucial for treatment decisions.
- Current methods for LNI prediction have limitations.
Purpose of the Study:
- To evaluate the predictive value of the Node Reporting and Data System (Node-RADS) for LNI in PCa.
- To assess Node-RADS utility in preoperative risk stratification using multiparametric MRI (mpMRI).
Main Methods:
- Retrospective analysis of 1,263 PCa patients undergoing radical prostatectomy (RP) and extended pelvic lymph node dissection (ePLND).
- Selected 94 patients with Briganti score ≥7% matched for key clinical factors.
- Node-RADS scores assigned from preoperative mpMRI; analyzed using logistic regression and ROC analysis.
Main Results:
- Node-RADS scores significantly predicted histopathologically confirmed LNI (p < 0.001).
- Node-RADS demonstrated strong diagnostic performance (AUC = 0.928) with 83.0% sensitivity and 91.5% specificity at cutoff ≥4.
- Traditional factors like PSA, Gleason score, and T stage did not significantly predict LNI.
Conclusions:
- Node-RADS provides a robust, standardized imaging approach for preoperative LNI assessment in PCa.
- Integrating Node-RADS can improve risk stratification and patient selection for ePLND.
- This may help reduce overtreatment in prostate cancer management.
Keywords:
Lymph node excisionLymphatic metastasisMagnetic resonance imagingMultiparametric magnetic resonance imagingNode Reporting and Data SystemProstatic neoplasmsRisk assessment

